Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Tingliang Jiang"'
Autor:
Zhao Cui, Huajing Wang, Shuo Li, Tingting Qin, Hang Shi, Ji Ma, Lanfang Li, Guihua Yu, Tingliang Jiang, Canghai Li
Publikováno v:
Journal of Pharmacological Sciences, Vol 148, Iss 1, Pp 73-85 (2022)
Although sorafenib (Sora) shows improved efficacy in clinical liver cancer therapy, its therapeutic efficacy is still greatly limited due to side effects as well as drug resistance. Thus new drug intervention strategies are imperative. Our research s
Externí odkaz:
https://doaj.org/article/17940fb6817d47859d026f49884f6f21
Autor:
Huajing Wang, Shuo Li, Zhao Cui, Tingting Qin, Hang Shi, Ji Ma, Lanfang Li, Guihua Yu, Tingliang Jiang, Canghai Li
Publikováno v:
Malaria Journal, Vol 20, Iss 1, Pp 1-12 (2021)
Abstract Background Malaria is a fatal disease that presents clinically as a continuum of symptoms and severity, which are determined by complex host-parasite interactions. Clearance of infection is believed to be accomplished by the spleen and monon
Externí odkaz:
https://doaj.org/article/f6399290321540f29a9b227d649037a0
Autor:
Shuo Li, Wenhui Xu, Huajing Wang, Tian Tang, Ji Ma, Zhao Cui, Hang Shi, Ting Qin, Hongying Zhou, Lanfang Li, Tingliang Jiang, Canghai Li
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 148, Iss , Pp 112742- (2022)
The activation of artemisinin and its derivatives (ARTs) to generate ROS and other free radicals is mainly heme- or ferrous iron-dependent. ARTs induce ferroptosis in tumor cells, although the involvement of ferroptosis in malaria remains unclear. We
Externí odkaz:
https://doaj.org/article/bba7a2922f7a4ceeba2ee88f4ee67065
Publikováno v:
Engineering, Vol 5, Iss 1, Pp 32-39 (2019)
Artemisinin and its derivatives represent the most important and influential class of drugs in the fight against malaria. Since the discovery of artemisinin in the early 1970s, the global community has made great strides in characterizing and underst
Externí odkaz:
https://doaj.org/article/2a5f65453b0a41ee811034ad92b12366
Publikováno v:
Molecules, Vol 24, Iss 10, p 1941 (2019)
Malaria is an infectious disease caused by Plasmodium group. The mechanisms of antimalarial drugs DHA/CQ are still unclear today. The inhibitory effects (IC50) of single treatments with DHA/CQ or V-ATPase inhibitor Baf-A1 or combination treatments by
Externí odkaz:
https://doaj.org/article/9ec1a90252cb48cebc83583192209ae0
Publikováno v:
The Lancet Infectious Diseases. 22:585-586
Autor:
Tingliang, Jiang, Baosheng, Zhao, Xinliang, Du, Changbin, Zhang, Feng, Sui, Lanfang, Li, Hongwei, Zhang
Publikováno v:
In World Science and Technology 2010 12(1):115-117
Publikováno v:
Engineering, Vol 5, Iss 1, Pp 32-39 (2019)
Artemisinin and its derivatives represent the most important and influential class of drugs in the fight against malaria. Since the discovery of artemisinin in the early 1970s, the global community has made great strides in characterizing and underst
Autor:
Jigang Wang, Yin-Kwan Wong, Tingliang Jiang, Xing Zhang, Nan Ma, Youyou Tu, Fulong Liao, Chengchao Xu, Hai-Ning Lyu, Yuqing Meng
Publikováno v:
Natural Product Reports.
Covering: Up to 2020 Artemisinin has made a significant contribution towards global malaria control since its initial discovery. Countless lives have been saved by this unique and miraculous molecule. In 2006, artemisinin-based combination therapies
Autor:
Ayola A. Adegnika, Selidji T Agnandji, Jigang Wang, Yin Kwan Wong, Chen Qiu, Tingliang Jiang, Yingke He, Fu Long Liao, Peter G. Kremsner, Amadou A. Sall, Zhen Liang, Sanjeev Krishna, Chengchao Xu, Youyou Tu
Publikováno v:
The Lancet